CONFERENCE COMMITTEE REP. NO. 88

 

Honolulu, Hawaii

                 , 2009

 

RE:    S.B. No. 932

       S.D. 2

       H.D. 2

       C.D. 1

 

 

 

Honorable Colleen Hanabusa

President of the Senate

Twenty-Fifth State Legislature

Regular Session of 2009

State of Hawaii

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Fifth State Legislature

Regular Session of 2009

State of Hawaii

 

Madam and Sir:

 

     Your Committee on Conference on the disagreeing vote of the Senate to the amendments proposed by the House of Representatives in S.B. No. 932, S.D. 2, H.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO INFECTIOUS DISEASE TESTING,"

 

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

 

     The purpose of this measure is to improve the early diagnosis of human immunodeficiency virus infections by removing significant procedural barriers to human immunodeficiency virus testing.

 

     Your Committee on Conference finds that this measure will enable early detection and treatment of the human immunodeficiency virus and lower the risk of transmitting the human immunodeficiency virus to others.

 

     Your Committee on Conference has amended this measure by changing the effective date to "upon approval".

 

 

     As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of S.B. No. 932, S.D. 2, H.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as S.B. No. 932, S.D. 2, H.D. 2, C.D. 1.

 

Respectfully submitted on behalf of the managers:

 

ON THE PART OF THE HOUSE

 

ON THE PART OF THE SENATE

 

____________________________

RYAN I. YAMANE, Co-Chair

 

____________________________

DAVID Y. IGE, Chair

____________________________

KEN ITO, Co-Chair

 

____________________________

BRIAN T. TANIGUCHI, Co-Chair